Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro)) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies

The Corona Virus Infectious Disease-2019 (COVID-19) outbreak originated at Wuhan, China, in December 2019. It has already spread rapidly and caused more than 6.5 million deaths worldwide. Its causal agent is a beta-coronavirus named SARS-CoV-2. Many efforts have already been made to develop new vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Dipesh Kumar, Kapoor, Srajan, Das, Satyajeet, Thakur, Krishan Gopal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856154/
https://www.ncbi.nlm.nih.gov/pubmed/36672593
http://dx.doi.org/10.3390/biomedicines11010085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856154/
https://www.ncbi.nlm.nih.gov/pubmed/36672593
http://dx.doi.org/10.3390/biomedicines11010085

Ejemplares similares